Rapid Therapeutic Science Laboratories (RTSL) Ratios
Rapid Therapeutic Science Laboratories Ratios
RTSL's free cash flow for Q2 2023 was $-7.33K. For the 2023 fiscal year, RTSL's free cash flow was increased by $5.00 and operating cash flow was $-7.33K. See a summary of the company’s cash flow.
| Ratios | Dec 22 | Dec 21 | Mar 20 | Mar 18 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 0.05 | 0.14 | 0.10 | 0.03 |
| Quick Ratio | 0.01 | 0.08 | 0.10 | 0.03 |
| Cash Ratio | 0.00 | 0.06 | 0.09 | 0.02 |
| Solvency Ratio | -0.31 | -1.16 | -0.19 | -0.88 |
| Operating Cash Flow Ratio | -0.23 | -0.72 | -0.07 | -0.19 |
| Short-Term Operating Cash Flow Coverage | -0.35 | -1.60 | -0.12 | -0.20 |
| Net Current Asset Value | $ -5.16M | $ -3.16M | $ -1.67M | $ -2.87M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 1.70 | 0.90 | 2.75 | 108.43 |
| Debt-to-Equity Ratio | -1.22 | -1.44 | -0.90 | -0.99 |
| Debt-to-Capital Ratio | 5.56 | 3.29 | -8.56 | -164.31 |
| Long-Term Debt-to-Capital Ratio | -0.05 | -0.12 | -0.30 | -3.32 |
| Financial Leverage Ratio | -0.72 | -1.59 | -0.33 | -0.01 |
| Debt Service Coverage Ratio | -0.22 | -1.27 | -0.15 | -0.24 |
| Interest Coverage Ratio | -0.67 | -1.64 | -0.94 | -88.23 |
| Debt to Market Cap | 0.59 | 0.80 | 36.24 | 22.19 |
| Interest Debt Per Share | 0.74 | 0.43 | 29.12 | 29.13 |
| Net Debt to EBITDA | -3.09 | -0.85 | -6.45 | -20.88 |
| Profitability Margins | ||||
| Gross Profit Margin | 0.00% | 62.55% | 21.71% | 0.00% |
| EBIT Margin | 0.00% | -406422.28% | -1856.77% | 0.00% |
| EBITDA Margin | 0.00% | -395961.80% | -1841.67% | 0.00% |
| Operating Profit Margin | 0.00% | -406422.28% | -1856.77% | 0.00% |
| Pretax Profit Margin | 0.00% | -537056.74% | -3817.06% | 0.00% |
| Net Profit Margin | 0.00% | -786015.73% | -3817.06% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | -786015.73% | 0.00% | 0.00% |
| Net Income Per EBT | 94.38% | 146.36% | 100.00% | 100.00% |
| EBT Per EBIT | 142.06% | 132.14% | 205.58% | 101.13% |
| Return on Assets (ROA) | -75.13% | -190.79% | -78.46% | -9728.35% |
| Return on Equity (ROE) | 53.92% | 303.77% | 25.57% | 89.18% |
| Return on Capital Employed (ROCE) | 46.60% | 254.43% | 16.17% | 380.94% |
| Return on Invested Capital (ROIC) | -173.00% | -359.49% | 118.44% | 14577.03% |
| Return on Tangible Assets | -81.26% | -206.78% | -245.51% | -11355.87% |
| Earnings Yield | -29.15% | -220.06% | -1034.77% | -1990.80% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.11 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.02 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -529536.53 | -3294.28 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 319460.78 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 848997.30 | 3294.28 | 0.00 |
| Operating Cycle | 0.00 | 319460.78 | 0.00 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -0.15 | -0.29 | -2.21 | -1.32 |
| Free Cash Flow Per Share | -0.15 | -0.33 | -5.43 | -1.71 |
| Dividend Paid and CapEx Coverage Ratio | -29.41 | -7.55 | -0.69 | -3.36 |
| Capital Expenditure Coverage Ratio | -29.41 | -7.55 | -0.69 | -3.36 |
| Operating Cash Flow Coverage Ratio | -0.30 | -1.11 | -0.09 | -0.05 |
| Operating Cash Flow to Sales Ratio | 0.00 | -4136.95 | -11.67 | 0.00 |
| Free Cash Flow Yield | -20.50% | -131.16% | -776.39% | -131.38% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -3.43 | -0.45 | -0.10 | -0.05 |
| Price-to-Sales (P/S) Ratio | 0.00 | 3571.90 | 3.69 | 0.00 |
| Price-to-Book (P/B) Ratio | -1.85 | -1.38 | -0.02 | -0.04 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.88 | -0.76 | -0.13 | -0.76 |
| Price-to-Operating Cash Flow Ratio | -5.04 | -0.86 | -0.32 | -0.99 |
| Price-to-Earnings Growth (PEG) Ratio | 0.06 | 0.00 | 0.00 | -0.00 |
| Enterprise Value Multiple | -7.78 | -1.75 | -6.65 | -21.83 |
| Enterprise Value | 9.64M | 3.70M | 1.12M | 2.96M |
| EV to EBITDA | -7.78 | -1.75 | -6.65 | -21.83 |
| EV to Sales | 0.00 | 6929.54 | 122.47 | 0.00 |
| EV to Free Cash Flow | -8.10 | -1.48 | -4.28 | -17.58 |
| EV to Operating Cash Flow | -8.37 | -1.68 | -10.49 | -22.80 |
| Tangible Book Value Per Share | -0.43 | -0.20 | -34.61 | -29.06 |
| Shareholders’ Equity Per Share | -0.41 | -0.18 | -28.33 | -29.02 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.06 | -0.46 | 0.00 | -0.01 |
| Revenue Per Share | 0.00 | 0.00 | 0.19 | 0.00 |
| Net Income Per Share | -0.22 | -0.55 | -7.24 | -25.88 |
| Tax Burden | 0.94 | 1.46 | 1.00 | 1.00 |
| Interest Burden | 1.42 | 1.32 | 2.06 | 0.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 3960.24 | 18.57 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 37.45 | 4.71 | 0.00 |
| Income Quality | 0.64 | 0.77 | 0.31 | 0.05 |
Currency in USD